Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Asymchem Laboratories’ New R&D Center Fully Operational

This article was originally published in PharmAsia News

Executive Summary

Asymchem Laboratories (Tianjin) recently opened its new R&D center in Tianjin. As one of the company's most important bases worldwide, the 10,000-square-meter facility will conduct new technology research on organic synthesis, medicinal chemistry, pharmaceutical preparation, as well as develop active pharmaceutical ingredient analysis and testing. Currently, Asymchem Laboratories' new GMP workshop and R&D center is operating at full capacity. The next phase will include construction of biolabs, a GMP pharmaceutical preparation workshop, a synthesis lab building and office block. The total value of the firm's output is expected to hit 2 billion yuan by 2010. (Click here for more - Chinese Language)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC069118

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel